RXST240719C62500
- 1.10
- +0.50+83.33%
RxSight Newsroom
Form 144 | RxSight(RXST.US) Officer Proposes to Sell 586.06K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $RxSight(RXST.US)$ Officer SHELLEY B THUNEN intends to sell 10,000 shares of its common stock on Jul 1, with a total market value of approximately $586.06K. SHELLEY B
Form 144 | RxSight(RXST.US) Officer Proposes to Sell 493.07K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $RxSight(RXST.US)$ Officer Thunen Shelley B intends to sell 8,402 shares of its common stock on Jul 1, with a total market value of approximately $493.07K. Thunen Shel
Institutional Investors Control 71% of RxSight, Inc. (NASDAQ:RXST) and Were Rewarded Last Week After Stock Increased 6.0%
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Is It Too Late To Consider Buying RxSight, Inc. (NASDAQ:RXST)?
RxSight, Inc. (NASDAQ:RXST), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NASDAQGM over the last few months. While good news for sh
RxSight Insider Sold Shares Worth $906,288, According to a Recent SEC Filing
Julie Andrews, Director, on June 14, 2024, sold 15,625 shares in RxSight (RXST) for $906,288. Following the Form 4 filing with the SEC, Andrews has control over a total of 30,287 shares of the company
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
RxSight(RXST.US) Director Sells US$906.29K in Common Stock
$RxSight(RXST.US)$ Director Andrews Julie sold 15,625 shares of common stock on Jun 14, 2024 at an average price of $58.0024 for a total value of $906.29K.Source: Announcement What is statement of cha
Form 144 | RxSight(RXST.US) Director Proposes to Sell 922.34K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $RxSight(RXST.US)$ Director Julie Andrews intends to sell 15,625 shares of its common stock on Jun 14, with a total market value of approximately $922.34K. Source: A
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to Its Board of Directors and Scientific Advisory Board
Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D.,
Investors Interested In RxSight, Inc.'s (NASDAQ:RXST) Revenues
RxSight, Inc.'s (NASDAQ:RXST) price-to-sales (or "P/S") ratio of 23.5x may look like a poor investment opportunity when you consider close to half the companies in the Medical Equipment industry in th
What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?
RxSight(RXST.US) Director Buys US$305.46K in Common Stock
$RxSight(RXST.US)$ Director Tammenoms Bakker Juliet purchased 5,000 shares of common stock on May 17, 2024 at an average price of $61.0913 for a total value of $305.46K.Source: Announcement What is st
Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing
Juliet Tammenoms Bakker, Director, on May 17, 2024, executed a purchase for 5,000 shares in Rxsight (RXST) for $305,457. Following the Form 4 filing with the SEC, Bakker has control over a total of 36
RxSight Raises $115 Million From Public Offering of Shares
RxSight (RXST) said it raised $115 million in gross proceeds from an underwritten public offering of nearly 2.1 million shares at $56 apiece. The offering includes full exercise by the underwriters of
Press Release: RxSight, Inc. Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Rx
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75
Why RxSight (RXST) Shares Are Falling
RxSight Inc (NASDAQ:RXST) shares are roughly flat following earlier weakness during Thursday's session after the company announced pricing of its $100 million proposed public offering of common stock.
RxSight Price Raises Equity at $56 per Share